Twist Bioscience Corporation

US$120.79As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TWSTHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR 30.82%
Div yield —
ROE (29.59%)
Biotechnology
Beta (5Y) 2.22
PE TTM —
TSR TTM 267.25%
Mkt cap US$7.574B
ROIC (15.30%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$120
(0.26%)
(23.03%)
Hold 12|8|1|11|3
1Q26
2Q26
3Q26
4Q26
Earnings per share$
2.29
2.47
2.40
2.29
0.59%
3.06%
3.46%
(0.75%)
Revenue$M
716.2
743.1
775.5
808.3
0.01%
4.07%
9.15%
11.54%
Peers (US$7.574B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.720
(0.573)
(0.523)
EBIT/Intx
0.663
1.112
0.744
Own earn%
51.78
80.82
74.63
Sh yield%
29.46
9.54
9.30
Owners
Insiders/Inst%
13.15
59.30
Short interest%
4.17
SBC / revenue%
0.45
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
19–25
$1 testx
—
Incr. ROIC%
8